Results 11 to 20 of about 1,503,516 (266)

Effect of sodium-glucose cotransporter-2 inhibitors on blood pressure in patients with heart failure: a systematic review and meta-analysis

Cardiovascular Diabetology, 2022
Background Recent studies have shown that sodium-glucose cotransporter-2 inhibitors (SGLT2i) can achieve significant improvement in blood pressure in people with diabetes. Furthermore, randomized controlled trials (RCTs) have established that SGLT2i have
Min Li, Tieci Yi, Fangfang Fan, Lin Qiu, Zhi Wang, Haoyu Weng, Wei Ma, Yan Zhang, Yong Huo   +8 more
doaj   +1 more source

Acknowledgement to Reviewers of Journal of Cardiovascular Development and Disease in 2018

Journal of Cardiovascular Development and Disease, 2019
Rigorous peer-review is the corner-stone of high-quality academic publishing[...]
Journal of Cardiovascular Development and Disease Editorial Office
doaj   +1 more source

Hyperuricemia is associated with metabolic syndrome in the community very elderly in Chengdu

Scientific Reports, 2020
Hyperuricemia is a risk factor for cardiovascular metabolic diseases. However, in the very elderly, the relationship between hyperuricemia and the metabolic syndrome (MetS) is not yet clear.
Gang Huang, Junbo Xu, Tingjie Zhang, Lin Cai, Hanxiong Liu, Xiuqiong Yu, Jing Wu   +6 more
doaj   +1 more source

Investigation of the Effects of Some Cardiovascular Drugs on Angiogenesis by Transgenic Zebrafish

Mediators of Inflammation, 2023
Introduction. Angiogenesis contributes to the pathophysiology of cardiovascular disease (CVD). Some cardiovascular drugs used in the treatment of CVD have an effect on the process of angiogenesis. Methods.
Hui Lv, Bo Liu, Yongwen Qin
doaj   +1 more source

Luteolin Pretreatment Ameliorates Myocardial Ischemia/Reperfusion Injury by lncRNA-JPX/miR-146b Axis

Analytical Cellular Pathology, 2023
Background. In the present study, we aimed to find out whether luteolin (Lut) pretreatment could ameliorate myocardial ischemia/reperfusion (I/R) injury by regulating the lncRNA just proximal to XIST (JPX)/microRNA-146b (miR-146b) axis. Methods.
Tongda Xu, Yuanyuan Zhang, Gege Liao, Haochen Xuan, Jie Yin, Jieli Bao, Yang Liu, Dongye Li   +7 more
doaj   +1 more source

Orthostatic variation of pulmonary artery pressure in ambulatory heart failure patients

BMC Cardiovascular Disorders, 2023
Aim To study effect of change in position (supine and standing) on pulmonary artery pressure (PAP) in ambulatory heart failure (HF) patients. Methods Seventeen patients with CardioMEMS® sensor and stable heart failure were consented and included in this ...
Prince Sethi, Prakash Acharya, Payton Lancaster, Brianna Stack, Kartik Munshi, Sagar Ranka, Zubair Shah, Andrew J. Sauer, Kamal Gupta   +8 more
doaj   +1 more source

Lysophosphatidic Acid Is Associated With Cardiac Dysfunction and Hypertrophy by Suppressing Autophagy via the LPA3/AKT/mTOR Pathway

Frontiers in Physiology, 2018
Background: Lysophosphatidic acid (LPA), as a phospholipid signal molecule, participates in the regulation of various biological functions. Our previous study demonstrated that LPA induces cardiomyocyte hypertrophy in vitro; however, the functional role ...
Jinjing Yang, Jinjing Yang, Jinjing Yang, Jiyao Xu, Jiyao Xu, Xuebin Han, Xuebin Han, Hao Wang, Yuean Zhang, Yuean Zhang, Jin Dong, Jin Dong, Yongzhi Deng, Yongzhi Deng, Jingping Wang, Jingping Wang   +15 more
doaj   +1 more source

Who Has Seen Patients With ST‐Segment–Elevation Myocardial Infarction? First Results From Italian Real‐World Coronavirus Disease 2019

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background After the coronavirus disease 2019 outbreak, social isolation measures were introduced to contain infection. Although there is currently a slowing down of the infection, a reduction of hospitalizations, especially for myocardial infarction ...
Valeria Cammalleri, Saverio Muscoli, Daniela Benedetto, Giuseppe Stifano, Massimiliano Macrini, Alessio Di Landro, Marco Di Luozzo, Massimo Marchei, Enrica Giuliana Mariano, Linda Cota, Domenico Sergi, Andrea Bezzeccheri, Michela Bonanni, Martino Baluci, Pasquale De Vico, Francesco Romeo   +15 more
doaj   +1 more source

Lipoprotein(a) in Cardiovascular Diseases [PDF]

BioMed Research International, 2013
Lipoprotein(a) (Lp(a)) is an LDL-like molecule consisting of an apolipoprotein B-100 (apo(B-100)) particle attached by a disulphide bridge to apo(a). Many observations have pointed out that Lp(a) levels may be a risk factor for cardiovascular diseases.
Malaguarnera M, Vacante M, Russo C, Malaguarnera G, Antic T, MALAGUARNERA, Lucia, BELLA, Rita, PENNISI, Giovanni, GALVANO, Fabio, Frigiola A.   +9 more
openaire   +3 more sources

Obesity and Cardiovascular Disease [PDF]

Circulation Research, 2016
The prevalence of obesity has increased worldwide over the past few decades. In 2013, the prevalence of obesity exceeded the 50% of the adult population in some countries from Oceania, North Africa, and Middle East. Lower but still alarmingly high prevalence was observed in North America (≈30%) and in Western Europe (≈20%). These figures are of serious
Ortega, Francisco B., Lavie, Carl J., Blair, Steven N.   +2 more
openaire   +5 more sources